These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1118 related articles for article (PubMed ID: 18181716)

  • 1. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.
    Mattia A; Merker R
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S115-8; discussion S144-51. PubMed ID: 18181714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
    McNamara SH
    Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
    [No Abstract]   [Full Text] [Related]  

  • 6. Market and product assessment of probiotic/prebiotic-containing functional foods and supplements manufactured in South Africa.
    Brink M; Senekal M; Dicks LM
    S Afr Med J; 2005 Feb; 95(2):114-9. PubMed ID: 15751206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. So you want to market a food and to make health-related claims--how far can you go? What rules of law will govern the claims you want to make?
    McNamara SH
    Food Drug Law J; 1998; 53(3):421-36. PubMed ID: 10346720
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality of manufacturer provided information on safety and efficacy claims for dietary supplements for colonic health.
    Hass DJ; Lewis JD
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):578-86. PubMed ID: 16700078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is my yogurt lying? Developing and applying a framework for determining whether wellness claims on probiotic yogurts mislead.
    Satine LA
    Food Drug Law J; 2008; 63(2):537-77. PubMed ID: 18561477
    [No Abstract]   [Full Text] [Related]  

  • 12. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
    Saxelin M
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current marketplace for probiotics: a Japanese perspective.
    Amagase H
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S73-5; discussion S144-51. PubMed ID: 18181727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of botanicals in food supplements. Regulatory scope, scientific risk assessment and claim substantiation. 2005.
    Coppens P; Delmulle L; Gulati O; Richardson D; Ruthsatz M; Sievers H; Sidani S;
    Ann Nutr Metab; 2006; 50(6):538-54. PubMed ID: 17191027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition function, health and related claims on packaged Australian food products--prevalence and compliance with regulations.
    Williams P; Yeatman H; Ridges L; Houston A; Rafferty J; Ridges A; Roesler L; Sobierajski M; Spratt B
    Asia Pac J Clin Nutr; 2006; 15(1):10-20. PubMed ID: 16500873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [State surveillance and control of food quality and safety in USA].
    Berman VA
    Vopr Pitan; 2003; 72(2):22-7. PubMed ID: 12924205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health claims: history, current regulatory status, and consumer research.
    Geiger CJ
    J Am Diet Assoc; 1998 Nov; 98(11):1312-22; discussion 1323-4. PubMed ID: 9813589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific substantiation of claims in the USA: focus on functional foods.
    Lupton JR
    Eur J Nutr; 2009 Dec; 48 Suppl 1():S27-31. PubMed ID: 19937443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.
    Gulati OP; Berry Ottaway P
    Toxicology; 2006 Apr; 221(1):75-87. PubMed ID: 16487647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.